AMSTERDAM, The Netherlands, Aug. 16, 2017 -- Wright Medical Group N.V. (NASDAQ:WMGI) announced today that it will present at the Baird 2017 Global Healthcare Conference on Wednesday, September 6, 2017, at the Intercontinental New York Barclay Hotel in New York, NY. Lance Berry, chief financial officer, will present at 1:25 p.m. Eastern Time.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be available on Wright’s corporate website at www.wright.com, under the “Investor Relations” link. The audio webcast and accompanying presentation materials will be archived on this site under the “Investor Presentations” link following the conference.
Internet Posting of Information
Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com. The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.
About Wright Medical Group N.V.
Wright Medical Group N.V. is a global medical device company focused on extremities and biologics products. The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics. For more information about Wright, visit www.wright.com.
Investors & Media: Julie D. Tracy Sr. Vice President, Chief Communications Officer Wright Medical Group N.V. (901) 290-5817 [email protected]


Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
OpenAI Explores Massive Funding Round at $750 Billion Valuation 



